Today: 7 February 2026
Subscribe

Monolithic Power Systems, Inc. (MPWR) Stock: Nasdaq-100 Addition, Dividend Update, and Fresh Analyst Forecasts as AI Data-Center Demand Builds

Monolithic Power Systems, Inc. (MPWR) Stock: Nasdaq-100 Addition, Dividend Update, and Fresh Analyst Forecasts as AI Data-Center Demand Builds

Dec. 20, 2025 — Monolithic Power Systems, Inc. (NASDAQ: MPWR) is ending 2025 in the spotlight after a cluster of catalysts that tends to matter for momentum-driven and fundamentals-driven investors alike: the stock is set to join the Nasdaq-100, the company reaffirmed its quarterly dividend, and Wall Street’s latest notes continue to frame MPWR as a key beneficiary of the AI data-center buildout—a theme that has been reshaping semiconductor leadership over the past year. Reuters+2Nasdaq+2 MPWR last traded around $937 (late Friday U.S. time), valuing the company at roughly $44 billion in market capitalization. The stock remains below its 52-week
20 December 2025
·
Exxon Mobil Stock (XOM) Today: 2030 Plan Upgrade, Buyback Outlook and Analyst Forecasts as Oil Slips Below $60

Exxon Mobil Stock (XOM) Today: 2030 Plan Upgrade, Buyback Outlook and Analyst Forecasts as Oil Slips Below $60

Date: December 20, 2025 Exxon Mobil Corporation (NYSE: XOM) heads into the final stretch of 2025 with a familiar mix of forces shaping its share price: weakening crude prices, a heavy focus on low-cost production growth (especially the Permian Basin and Guyana), and investors’ ongoing appetite for dividends and buybacks. XOM last closed at $116.69 on Friday, December 19, 2025 (markets were closed Saturday), finishing slightly higher on the day after a choppy week of trading. StockAnalysis What’s new—and why it matters for Exxon stock right now—is that the company has raised its 2030 corporate plan targets while simultaneously leaning
20 December 2025
··
Salesforce (CRM) Stock News and Forecasts on Dec. 20, 2025: Agentforce AI Momentum, Qualified Acquisition, and Wall Street Price Targets

Salesforce (CRM) Stock News and Forecasts on Dec. 20, 2025: Agentforce AI Momentum, Qualified Acquisition, and Wall Street Price Targets

December 20, 2025 — Salesforce, Inc. (NYSE: CRM) stock is heading into the final stretch of 2025 at the center of a debate investors know well: is this a beaten-down software leader becoming a bargain again, or a “value trap” in a market that’s rewarding AI infrastructure over traditional SaaS? MarketWatch On price action, Salesforce shares last traded around $259.91, after closing Friday, Dec. 19, 2025 at $259.91, up 0.80% on the day, with roughly 20.7 million shares traded. Investing.com What’s driving attention this weekend isn’t a single headline—it’s the convergence of AI commercialization, fresh M&A, and renewed analyst conviction
20 December 2025
···
AppLovin (APP) Stock Update Dec. 20, 2025: Why Shares Are Surging, Fresh Analyst Targets, and the Next Catalysts

AppLovin (APP) Stock Update Dec. 20, 2025: Why Shares Are Surging, Fresh Analyst Targets, and the Next Catalysts

AppLovin Corporation (NASDAQ: APP) has become one of the market’s most closely watched adtech and AI-driven marketing stories—especially as investors debate how much runway remains in its e-commerce expansion and how durable its mobile gaming advertising strength will be into 2026. As of Dec. 20, 2025 (Saturday), U.S. markets are closed, so the most recent official close is Friday, Dec. 19. AppLovin stock finished that session at $721.37, up about 3.9% on the day, with after-hours trading around $725 in some feeds. MarketBeat+2Stock Analysis+2 Below is a comprehensive, publication-ready roundup of today’s key AppLovin stock news drivers, current forecasts and
20 December 2025
CoreWeave (CRWV) Stock News and Forecasts for Dec. 20, 2025: DOE “Genesis Mission” Boosts Shares as Analysts Debate AI Data-Center Risks

CoreWeave (CRWV) Stock News and Forecasts for Dec. 20, 2025: DOE “Genesis Mission” Boosts Shares as Analysts Debate AI Data-Center Risks

CoreWeave, Inc. (NASDAQ: CRWV) ends the week back in the spotlight after a sharp Friday rebound that partially reversed a bruising late-2025 selloff. As of the Dec. 19, 2025 close (the last trading session ahead of Dec. 20), CoreWeave shares finished around $83, up roughly 22% on the day, according to MarketBeat’s end-of-day quote. MarketBeat The catalyst wasn’t a single headline—it was a “stack” of market-moving signals that hit within roughly 24–48 hours: That rebound arrives after weeks of volatile trading tied to a broader market debate: whether the AI infrastructure buildout is a durable, cash-generating megatrend—or the early innings
20 December 2025
··
Lamb Weston (LW) Stock Plunges After Earnings Beat: Margin Pressure, 2026 Outlook, and Analyst Forecasts as of Dec. 20, 2025

Lamb Weston (LW) Stock Plunges After Earnings Beat: Margin Pressure, 2026 Outlook, and Analyst Forecasts as of Dec. 20, 2025

Lamb Weston Holdings, Inc. (NYSE: LW) is back in the market’s spotlight this weekend—and not because investors suddenly stopped liking French fries. After reporting second-quarter fiscal 2026 results that beat Wall Street expectations on revenue and adjusted earnings, Lamb Weston shares still fell sharply as investors zeroed in on what management said comes next: continued discounting, unfavorable price/mix, and higher international manufacturing costs that could keep profitability under pressure into the back half of the year. Barron’s+2Reuters+2 Below is what actually happened, what the company guided for fiscal 2026, and how analysts and market watchers are framing the bull case
20 December 2025
···
Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next

Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next

Disc Medicine, Inc. (NASDAQ: IRON) stock is seeing a classic “biotech catalyst storm” on Dec. 20, 2025: big intraday swings, headline-driven volatility, and analysts arguing over whether the market is repricing risk or merely repricing uncertainty. As of the latest trading data available, IRON was around $80.04, down roughly 11.5% versus the prior close, after trading as high as $94.60 and as low as $71.46 on heavy volume (about 4.22 million shares). The immediate trigger: a report-driven debate about the FDA’s new fast-track voucher process and whether Disc’s lead drug candidate, bitopertin, remains on the clean, accelerated path bulls were
20 December 2025
·
Intel Stock News Today (Dec. 20, 2025): Nvidia’s $5B Deal Clears, Intel Foundry Hits a Key 14A Milestone, and What Wall Street Forecasts for INTC

Intel Stock News Today (Dec. 20, 2025): Nvidia’s $5B Deal Clears, Intel Foundry Hits a Key 14A Milestone, and What Wall Street Forecasts for INTC

December 20, 2025 — Intel Corporation (NASDAQ: INTC) heads into the final stretch of 2025 with two narratives colliding: a high-profile partnership boost that removes a major regulatory overhang, and a “show-me” execution story that still hinges on foundry credibility, geopolitics, and earnings follow-through. As of the latest available quote early Saturday (UTC), Intel shares traded around $36.82, with heavy volume indicated versus typical sessions (noting that U.S. equity markets are closed on weekends and quotes can reflect delayed or off-session data). Below is what matters for Intel stock on 20.12.2025—the biggest headlines moving sentiment, the most-cited forecasts and price
20 December 2025
··
Applied Digital Corporation Stock (APLD): Latest News, Earnings Outlook, Analyst Forecasts, and Key Risks as of Dec. 20, 2025

Applied Digital Corporation Stock (APLD): Latest News, Earnings Outlook, Analyst Forecasts, and Key Risks as of Dec. 20, 2025

Applied Digital Corporation (NASDAQ: APLD) is ending the week the way only an AI-infrastructure “picks-and-shovels” stock can: with a bruising selloff, a sharp rebound, and investors arguing about whether the company is building the future—or building a debt tower during an interest-rate era that does not forgive. On Friday, Dec. 19, APLD surged 16.53% to close at $27.85, after trading between $24.33 and $27.89 in the session, according to AAII’s recap. aaii.com That jump followed a volatile stretch where the market’s mood swung between “AI data centers are inevitable” and “okay, but who pays for all this concrete, copper, power,
20 December 2025
··
Eli Lilly (LLY) Stock Outlook on Dec. 20, 2025: Orforglipron Pill Data, Price Cuts, and 2026 Forecasts Put the $1 Trillion Drugmaker Back in Focus

Eli Lilly (LLY) Stock Outlook on Dec. 20, 2025: Orforglipron Pill Data, Price Cuts, and 2026 Forecasts Put the $1 Trillion Drugmaker Back in Focus

Dec. 20, 2025 — Eli Lilly and Company (NYSE: LLY) is closing out 2025 with momentum—and with fresh headlines that underscore why Eli Lilly stock has become one of the market’s most closely watched healthcare names. Shares last closed at $1,071.44 (Dec. 19) after trading between $1,059.01 and $1,075.38, keeping the stock within reach of its recent highs. Stock Analysis The bigger story isn’t just the price. Lilly entered the rarefied “$1 trillion market value” club this year—an inflection point for a pharmaceutical company—and it’s doing so on the back of a rapidly expanding obesity and cardiometabolic franchise, a pipeline
20 December 2025
···
BioMarin (BMRN) Stock Surges on $4.8B Amicus Deal: Latest News, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

BioMarin (BMRN) Stock Surges on $4.8B Amicus Deal: Latest News, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ended Friday’s session sharply higher after announcing a blockbuster rare-disease acquisition that immediately reframed the company’s growth story. Shares closed at $61.15, up about 17.7% on the day, with trading volume far above typical levels—classic “big-news repricing” behavior. Yahoo Finance The catalyst: BioMarin’s agreement to buy Amicus Therapeutics (NASDAQ: FOLD) for $14.50 per share in cash, valuing the deal at approximately $4.8 billion. BioMarin says the acquisition adds two marketed, growing therapies—Galafold (Fabry disease) and Pombiliti + Opfolda (Pompe disease)—plus U.S. rights to DMX-200 (a Phase 3 kidney-disease asset), while also resolving a key piece
20 December 2025
··
Nike Stock (NKE) Slides After Fiscal Q2 2026 Earnings: Tariffs, China Weakness, Analyst Price Targets and the 2026 Outlook

Nike Stock (NKE) Slides After Fiscal Q2 2026 Earnings: Tariffs, China Weakness, Analyst Price Targets and the 2026 Outlook

Nike, Inc. (NYSE: NKE) is ending the week under intense investor scrutiny after a sharp post-earnings selloff reset expectations for the company’s turnaround. As of Dec. 20, 2025 (with U.S. markets closed for the weekend), Nike shares last closed at $58.71, down $6.92 (−10.54%) on unusually heavy volume, reflecting a market that’s increasingly focused on near-term margin pressure and China execution rather than a modest revenue beat. The move came after Nike reported fiscal second-quarter 2026 results (quarter ended Nov. 30, 2025) that topped profit expectations but highlighted three issues that continue to dominate the Nike stock narrative: tariff-driven cost
20 December 2025
···
Carnival Corporation & plc Stock (NYSE: CCL) Jumps on Dividend Return, Record FY2025 Results, and a 2026 Outlook That Has Analysts Repricing the Cruise Giant

Carnival Corporation & plc Stock (NYSE: CCL) Jumps on Dividend Return, Record FY2025 Results, and a 2026 Outlook That Has Analysts Repricing the Cruise Giant

Carnival Corporation & plc stock is closing out 2025 with the kind of headline stack investors usually reserve for a comeback movie: record full‑year profit and revenue, investment‑grade leverage metrics, the first dividend in more than five years, and a proposal to simplify its unusual dual‑listed structure. The market’s initial reaction was loud—CCL finished Friday (Dec. 19) up about 9.8% at $31.12 after trading as high as $31.49, with volume north of 83 million shares. StockAnalysis This weekend’s coverage (Dec. 20, 2025) has focused on three big questions for anyone watching Carnival stock: Below is what’s new, what’s forecast, and
20 December 2025
···
Visa Stock News Today (NYSE: V): USDC Stablecoin Settlement, Legal Updates, and Wall Street Forecasts for 2026

Visa Stock News Today (NYSE: V): USDC Stablecoin Settlement, Legal Updates, and Wall Street Forecasts for 2026

December 20, 2025 — Visa Inc. (NYSE: V) is closing out the week with investors weighing a busy stretch of product headlines, regulatory developments, and analyst upgrades. Visa shares last traded around $349.25 on Dec. 19 (the most recent U.S. session), up 0.94% on the day, with a 52‑week range of $299.00 to $375.51, according to the company’s stock quote page. Visa Investor Relations While the calendar is moving into year-end, the story around Visa stock is still in motion: stablecoins are shifting from “disruption” to “distribution,” AI-powered commerce is moving from demos into controlled real-world transactions, and legal headlines
20 December 2025
··
Western Digital Stock (NASDAQ: WDC) News and Forecast for Dec. 20, 2025: Nasdaq-100 Inclusion, Analyst Upgrades, and the AI Storage Supercycle

Western Digital Stock (NASDAQ: WDC) News and Forecast for Dec. 20, 2025: Nasdaq-100 Inclusion, Analyst Upgrades, and the AI Storage Supercycle

December 20, 2025 — Western Digital Corporation (NASDAQ: WDC) is closing out 2025 as one of the market’s most talked-about “infrastructure for AI” plays, with shares hovering around $181 after a volatile, high-volume session that saw the stock trade between roughly $176 and $185. Behind the move is a rare combination of catalysts hitting at once: Western Digital’s imminent addition to the Nasdaq-100, a fresh wave of Wall Street price-target hikes, and a business narrative increasingly tied to AI data-center storage demand—the kind of “picks-and-shovels” theme investors have chased across tech in 2025. ir.nasdaq.com+2Investing.com+2 Below is a detailed roundup of
20 December 2025
·
Rocket Lab Stock (RKLB) Hits Record High After $816M U.S. Space Force Satellite Win: News, Forecasts, and What’s Next

Rocket Lab Stock (RKLB) Hits Record High After $816M U.S. Space Force Satellite Win: News, Forecasts, and What’s Next

Rocket Lab Corporation (NASDAQ: RKLB) closed at a fresh all-time high on Friday, December 19, after landing its largest contract to date: a major U.S. Space Force-linked award to build missile-defense satellites for the Space Development Agency (SDA). The move capped off a volatile, news-packed stretch for the company—one that also included a high-profile U.S. Space Force launch completed months ahead of schedule, a first dedicated mission for Japan’s space agency, and continued drumbeat updates on Rocket Lab’s next-generation Neutron rocket program. SDA+3MarketWatch+3Investing.com+3 As of Saturday, December 20, 2025 (U.S. markets closed), the latest official close being digested by investors
20 December 2025
·
Ondas Holdings (ONDS) Stock Surges on Defense Robotics Momentum: Latest News, Forecasts, and Analyst Views (Dec. 20, 2025)

Ondas Holdings (ONDS) Stock Surges on Defense Robotics Momentum: Latest News, Forecasts, and Analyst Views (Dec. 20, 2025)

December 20, 2025 — Ondas Holdings Inc. (NASDAQ: ONDS) is back in the spotlight after a sharp, high-volume move to close Friday, December 19, 2025 at $9.22, up 18.21% in a single session. Trading volume also spiked to roughly 125 million shares, a “something big is happening” kind of number for a company of this size. Ondas Holdings Inc. The rally didn’t arrive out of nowhere. Over the past three weeks—especially in mid-December—Ondas has stacked a rapid sequence of defense-and-security-focused headlines: leadership expansion, acquisition integration, a European industrial cooperation push, counter-drone orders, and an AI-driven demining pilot with measurable real-world
20 December 2025
···
Applied Materials Stock (AMAT) News Today: Analyst Targets Rise on AI Chip Demand, Even as China Export Curbs Loom

Applied Materials Stock (AMAT) News Today: Analyst Targets Rise on AI Chip Demand, Even as China Export Curbs Loom

Dec. 20, 2025 — Applied Materials, Inc. (NASDAQ: AMAT) is ending the week near recent highs after a volatile stretch that featured a fresh 52‑week peak, heavy trading volume, and a steady drumbeat of analyst updates tied to the AI-led semiconductor buildout. The latest U.S. session (Friday, Dec. 19, 2025) saw Applied Materials stock close at $256.41, up 1.15% on the day. That close leaves AMAT about 7% below its 52‑week high of $276.10, set on Dec. 10, and it came with volume around 25.3 million shares, well above the stock’s recent average. MarketWatch For investors watching AMAT stock into
20 December 2025
Edgewise Therapeutics (EWTX) Stock: Latest News, Analyst Forecasts, and What’s Driving the December 2025 Surge

Edgewise Therapeutics (EWTX) Stock: Latest News, Analyst Forecasts, and What’s Driving the December 2025 Surge

Edgewise Therapeutics, Inc. (Nasdaq: EWTX) is ending mid-December 2025 in classic clinical-stage biotech fashion: big percentage swings, a sharp momentum breakout, and investors trying to decide whether the move is “new information” or simply “new positioning.” As of Saturday, December 20, 2025, EWTX is being widely quoted around $25.55—a level reached after a powerful jump in the prior U.S. session. StockAnalysis+1 What matters for readers tracking the stock isn’t just the price print. It’s the why: a late-stage neuromuscular story (sevasemten), a closely watched cardiovascular program (EDG-7500), and a pipeline that can re-rate quickly on clinical updates—up or down. PR
20 December 2025
·
Lam Research (LRCX) Stock News Today: Record High, Analyst Upgrades to $200, and 2026 Outlook (Dec. 20, 2025)

Lam Research (LRCX) Stock News Today: Record High, Analyst Upgrades to $200, and 2026 Outlook (Dec. 20, 2025)

Lam Research Corporation (NASDAQ: LRCX) is ending the week on a sharp upswing after a volatile December stretch—and the latest headlines on December 20, 2025 point to a clear driver: a cluster of analyst upgrades and price-target hikes tied to strengthening AI- and memory-led semiconductor spending expectations. With U.S. markets closed on Saturday, the most recent tape investors are working from is Friday, Dec. 19, when Lam Research stock closed at $172.27 (+4.60%), after trading as high as $173.58 on unusually heavy volume. Investing.com+1 Below is a comprehensive roundup of the current news, forecasts, and analyses circulating on 20.12.2025, plus
20 December 2025
·
1 … 831 832 833 834 835 … 1,635

Stock Market Today

L’Oreal share price slips into weekend as OR.PA heads for annual results test

L’Oreal share price slips into weekend as OR.PA heads for annual results test

7 February 2026
L’Oréal shares closed at 394.05 euros in Paris on Friday, down 0.16%, marking a second straight session of losses. The company will release its 2025 annual results after markets close on Feb. 12, with a financial meeting set for Feb. 13. About 319,000 shares traded Friday in a range between 385.70 and 395.10 euros. The STOXX 600 rose 0.9% to 617.12 points.
RBC stock heads into new week near C$233 after Canada jobs surprise

RBC stock heads into new week near C$233 after Canada jobs surprise

7 February 2026
Royal Bank of Canada shares closed Friday up 0.7% at C$232.72, trailing gains by other major Canadian banks. Canada’s main stock index surged 1.5% as metals rebounded. January jobs data showed a loss of 24,800 positions but a lower 6.5% unemployment rate. RBC’s Q1 earnings are due Feb. 26.
Go toTop